Abstract

Coxsackievirus B3 (CVB3) is an enterovirus of the family of Picornaviridae. The Group B coxsackieviruses include six serotypes (B1 to B6) that cause a variety of human diseases, including myocarditis, meningitis, and diabetes. Among the group B, the B3 strain is mostly studied for its cardiovirulence and its ability to cause acute and persistent infections. Translation initiation of CVB3 RNA has been shown to be mediated by a highly ordered structure of the 5′-untranslated region (5′UTR), which harbors an internal ribosome entry site (IRES). Translation initiation is a complex process in which initiator tRNA, 40S and 60S ribosomal subunits are assembled by eukaryotic initiation factors (eIFs) into an 80S ribosome at the initiation codon of the mRNA. We have previously addressed the question of whether the attenuating mutations of domain V of the poliovirus IRES were specific for a given genomic context or whether they could be transposed and extrapolated to a genomic related virus, i.e., CVB3 wild-type strain. In this context, we have described that Sabin3-like mutation (U473→C) introduced in CVB3 genome led to a defective mutant with a serious reduction in translation efficiency. In this study, we analyzed the efficiency of formation of ribosomal initiation complexes 48S and 80S through 10%–30% and 10%–50% sucrose gradients using rabbit reticulocyte lysates (RRLs) and stage-specific translation inhibitors: 5′-Guanylyl-imidodiphosphate (GMP-PNP) and Cycloheximide (CHX), respectively. We demonstrated that the interaction of 48S and 80S ribosomal complexes within the mutant CVB3 RNA was abolished compared with the wild-type RNA by ribosome assembly analysis. Taken together, it is possible that the mutant RNA was unable to interact with some trans-acting factors critical for enhanced IRES function.

Highlights

  • Coxsackievirus B3 (CVB3), a member of the genus enterovirus within the family Picornaviridae, is an established human pathogen that causes heart disease [1,2,3], pancreatitis [4,5,6,7] and meningoencephalitis [8,9]

  • CVB3 internal ribosome entry site (IRES) RNA, we developed an assay that allowed us to determine the efficiency of ribosome association with the mutated IRES elements

  • We demonstrated that the efficiency of ribosome assembly with the mutated IRES was considerably impaired compared with the wild-type

Read more

Summary

Introduction

Coxsackievirus B3 (CVB3), a member of the genus enterovirus within the family Picornaviridae, is an established human pathogen that causes heart disease [1,2,3], pancreatitis [4,5,6,7] and meningoencephalitis [8,9]. Cardiovirulence of coxsackieviruses was demonstrated by extensive inflammatory lesions and necrosis of heart tissue [12,13,14]. These infections are difficult to treat and, to date, no approved vaccine is available. Efforts have been made to develop a vaccine against CVB3. These include an inactivated vaccine [15], several live attenuated viruses [16,17,18,19,20] and DNA vaccines [21,22]

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.